|
1
|
Friedmann-Morvinski D, Bushong EA, Ke E,
Soda Y, Marumoto T, Singer O, Ellisman MH and Verma IM:
Dedifferentiation of neurons and astrocytes by oncogenes can induce
gliomas in mice. Science. 338:1080–1084. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Arshad A Arif: S.H: EGFR and PTEN gene
mutation status in glioblastoma patients and their prognostic
impact on patient's survival. J Carcinog Muta. 6:2015.
|
|
3
|
Virk SM, Gibson RM, Quinones-Mateu ME and
Barnholtz-Sloan JS: Identification of variants in primary and
recurrent glioblastoma using a cancer-specific gene panel and whole
exome sequencing. PLoS One. 10:e01241782015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bergers G and Benjamin LE: Tumorigenesis
and the angiogenic switch. Nat Rev Cancer. 3:401–410. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wesseling P, Ruiter DJ and Burger PC:
Angiogenesis in brain tumors; pathobiological and clinical aspects.
J Neurooncol. 32:253–265. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jain RK, di Tomaso E, Duda DG, Loeffler
JS, Sorensen AG and Batchelor TT: Angiogenesis in brain tumours.
Nat Rev Neurosci. 8:610–622. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Das S and Marsden PA: Angiogenesis in
glioblastoma. N Engl J Med. 369:1561–1563. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Carmeliet P and Jain RK: Molecular
mechanisms and clinical applications of angiogenesis. Nature.
473:298–307. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Norden AD, Drappatz J and Wen PY: Novel
anti-angiogenic therapies for malignant gliomas. Lancet Neurol.
7:1152–1160. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chinot OL, Macdonald DR, Abrey LE,
Zahlmann G, Kerloëguen Y and Cloughesy TF: Response assessment
criteria for glioblastoma: Practical adaptation and implementation
in clinical trials of antiangiogenic therapy. Curr Neurol Neurosci
Rep. 13:3472013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chinot OL, Wick W, Mason W, Henriksson R,
Saran F, Nishikawa R, Carpentier AF, Hoang-Xuan K, Kavan P, Cernea
D, et al: Bevacizumab plus radiotherapy-temozolomide for newly
diagnosed glioblastoma. N Engl J Med. 370:709–722. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gilbert MR, Dignam JJ, Armstrong TS, Wefel
JS, Blumenthal DT, Vogelbaum MA, Colman H, Chakravarti A, Pugh S,
Won M, et al: A randomized trial of bevacizumab for newly diagnosed
glioblastoma. N Engl J Med. 370:699–708. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ekstrand MI, Falkenberg M, Rantanen A,
Park CB, Gaspari M, Hultenby K, Rustin P, Gustafsson CM and Larsson
NG: Mitochondrial transcription factor A regulates mtDNA copy
number in mammals. Hum Mol Genet. 13:935–944. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Picca A and Lezza AM: Regulation of
mitochondrial biogenesis through TFAM-mitochondrial DNA
interactions: Useful insights from aging and calorie restriction
studies. Mitochondrion. 25:67–75. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cheng Z and Ristow M: Mitochondria and
metabolic homeostasis. Antioxidants & redox signaling.
19:240–242. 2013. View Article : Google Scholar
|
|
16
|
Kim AY, Kwak JH, Je NK, Lee YH and Jung
YS: Epithelial-mesenchymal transition is associated with acquired
resistance to 5-fluorocuracil in HT-29 colon cancer cells. Toxicol
Res. 31:151–156. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li Y, Park J, Piao L, Kong G, Kim Y, Park
KA, Zhang T, Hong J, Hur GM, Seok JH, et al: PKB-mediated PHF20
phosphorylation on Ser291 is required for p53 function in DNA
damage. Cell Signal. 25:74–84. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim IS, Yang SY, Han JH, Jung SH, Park HS
and Myung CS: Differential gene expression in GPR40-overexpressing
pancreatic β-cells treated with linoleic acid. Korean J Physiol
Pharmacol. 19:141–149. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bioinformatics UG: 2015, Human genome
sequencing consortium. http://genome.ucsc.eduApril 17–2016
|
|
20
|
Kim D and Salzberg S: 2015, TopHat 2.1.0
release 6/29/2015. https://ccb.jhu.edu/software/tophat/index.shtml
|
|
21
|
Na CH, Hong JH, Kim WS, Shanta SR, Bang
JY, Park D, Kim HK and Kim KP: Identification of protein markers
specific for papillary renal cell carcinoma using imaging mass
spectrometry. Mol Cells. 38:624–629. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jiang J, Yang J, Wang Z, Wu G and Liu F:
TFAM is directly regulated by miR-23b in glioma. Oncol Rep.
30:2105–2110. 2013.PubMed/NCBI
|
|
23
|
Chargari C, Moncharmont C, Lévy A, Guy JB,
Bertrand G, Guilbert M, Rousseau C, Védrine L, Alphonse G, Toillon
RA, et al: Cancer stem cells, cornerstone of radioresistance and
perspectives for radiosensitization: Glioblastoma as an example.
Bull Cancer. 99:1153–1160. 2012.(In French). PubMed/NCBI
|
|
24
|
Yoshida T, Azuma H, Aihara K, Fujimura M,
Akaike M, Mitsui T and Matsumoto T: Vascular smooth muscle cell
proliferation is dependent upon upregulation of mitochondrial
transcription factor A (mtTFA) expression in injured rat carotid
artery. Atherosclerosis. 178:39–47. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kim AJ, Jee HJ, Song N, Kim M, Jeong SY
and Yun J: p21 (WAF1/C1P1) deficiency induces mitochondrial
dysfunction in HCT116 colon cancer cells. Biochem Biophys Res
Commun. 430:653–658. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Guo J, Zheng L and Liu W, Wang X, Wang Z,
Wang Z, French AJ, Kang D, Chen L, Thibodeau SN and Liu W: Frequent
truncating mutation of TFAM induces mitochondrial DNA depletion and
apoptotic resistance in microsatellite-unstable colorectal cancer.
Cancer Res. 71:2978–2987. 2011. View Article : Google Scholar : PubMed/NCBI
|
